Abstract.
RET is the receptor for glial-derived neurotrophic factor growth factors. It is a paradigm of a single gene that causes different types of human cancer when targeted by different genetic alterations. Like other receptor tyrosine kinases, once activated, RET recruits a variety of signaling molecules that mediate biological responses. Here we review data on the signaling pathways that lead to RET-mediated cell transformation and recent evidence that manipulation of RET holds promise for thyroid cancer treatment.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Santoro, M., Carlomagno, F., Melillo, R.M. et al. Oncogenic protein tyrosine kinases. CMLS, Cell. Mol. Life Sci. 61, 2954–2964 (2004). https://doi.org/10.1007/s00018-004-4276-8
Issue Date:
DOI: https://doi.org/10.1007/s00018-004-4276-8